Menu Search
Equities

M1 Kliniken AG

M12:DEU

M1 Kliniken AG

Actions
  • Price (EUR)16.45
  • Today's Change0.25 / 1.54%
  • Shares traded13.97k
  • 1 Year change+81.17%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

M1 Kliniken AG, formerly M1 Beauty AG, is a Germany-based operator of healthcare facilities and provider of related services. The Company operates a chain of medical centers for aesthetic and plastic treatments, such as wrinkle treatments, lip treatments, breast corrections, liposuction, tummy tucks, upper arm lift, upper thigh lift, face lift, upper eyelid lift and the correction of labia, among others. In addition, the Company provides consultation services with registered doctors and specialists. It operates medical centers in Berlin, Essen, Dusseldorf, Cologne and Munich.

  • Revenue in EUR (TTM)333.27m
  • Net income in EUR16.76m
  • Incorporated2007
  • Employees174.00
  • Location
    M1 Kliniken AGGruenauer Strasse 5BERLIN 12557GermanyDEU
  • Phone+49 30 347474414
  • Fax+49 30 347474417
  • Websitehttps://www.m1-kliniken.de/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.